Norcross, GA – According to filings with the U.S. Securities and Exchange Commission, TendoNova is raising $2,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Mark Samuels played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About TendoNova
TendoNova is developing a suite of affordable specialized tools for minimally invasive orthopedic procedures that can be performed under ultrasound guidance in the physicians office. Starting with chronic tendon pain, TendoNova seeks to provide clinicians with modalities that are customizable to individual patient needs without overwhelming expense. By bringing surgical level care to the office we increase patient access to clinically proven treatments.

To learn more about TendoNova, visit http://www.tendonova.com/

Contact:
Mark Samuels, Chief Executive Officer
470-588-0420
https://www.linkedin.com/in/marksamuelsinatlanta/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved